Skip to main content
Traci (Depalma) Schilling, MD, Neurology, Waterville, ME

TraciB(Depalma)SchillingMD

Neurology Waterville, ME

Neurophysiology

Physician

Are you Dr. Schilling?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 36 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    180 Kennedy Memorial Dr
    Ste 203
    Waterville, ME 04901
    Phone+1 207-861-7050
    Fax+1 207-861-7056

Summary

  • Dr. Traci (Depalma) Schilling, MD is a neurologist in Waterville, Maine. She is currently licensed to practice medicine in Maine.

Education & Training

  • Brown University
    Brown UniversityFellowship, Clinical Neurophysiology, 2006 - 2007
  • NYU Grossman School of Medicine
    NYU Grossman School of MedicineResidency, Neurology, 2003 - 2006
  • Zucker School of Medicine at Hofstra/Northwell at Staten Island University Hospital
    Zucker School of Medicine at Hofstra/Northwell at Staten Island University HospitalInternship, Internal Medicine, 2002 - 2003
  • State University of New York Downstate Medical Center College of Medicine
    State University of New York Downstate Medical Center College of MedicineClass of 2002

Certifications & Licensure

  • ME State Medical License
    ME State Medical License 2009 - 2026
  • National Board of Physicians and Surgeons Neurology
  • National Board of Physicians and Surgeons Neuromuscular Medicine

Awards, Honors, & Recognition

  • Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014

Publications & Presentations

PubMed

Press Mentions

  • Hospital Utilization Rates Following Antipsychotic Dose Reduction in Mood Disorders: Implications for Treatment of Tardive Dyskinesia
    Hospital Utilization Rates Following Antipsychotic Dose Reduction in Mood Disorders: Implications for Treatment of Tardive DyskinesiaJuly 11th, 2020